1. Academic Validation
  2. Cdc42 is a key regulator of B cell differentiation and is required for antiviral humoral immunity

Cdc42 is a key regulator of B cell differentiation and is required for antiviral humoral immunity

  • J Exp Med. 2015 Jan 12;212(1):53-72. doi: 10.1084/jem.20141143.
Marianne Burbage 1 Selina J Keppler 1 Francesca Gasparrini 1 Nuria Martínez-Martín 1 Mauro Gaya 1 Christoph Feest 1 Marie-Charlotte Domart 1 Cord Brakebusch 2 Lucy Collinson 1 Andreas Bruckbauer 1 Facundo D Batista 3
Affiliations

Affiliations

  • 1 Lymphocyte Interaction Laboratory, Electron Microscopy Unit, London Research Institute, Cancer Research UK, London WC2A 3LY, England, UK.
  • 2 Biomedical Institute, Biotech Research and Innovation Centre, University of Copenhagen, 2100 Copenhagen, Denmark.
  • 3 Lymphocyte Interaction Laboratory, Electron Microscopy Unit, London Research Institute, Cancer Research UK, London WC2A 3LY, England, UK facundo.batista@cancer.org.uk.
Abstract

The small Rho GTPase Cdc42, known to interact with Wiskott-Aldrich syndrome (WAS) protein, is an important regulator of actin remodeling. Here, we show that genetic ablation of Cdc42 exclusively in the B cell lineage is sufficient to render mice unable to mount antibody responses. Indeed Cdc42-deficient mice are incapable of forming germinal centers or generating plasma B cells upon either viral Infection or immunization. Such severe immune deficiency is caused by multiple and profound B cell abnormalities, including early blocks during B cell development; impaired antigen-driven BCR signaling and actin remodeling; defective antigen presentation and in vivo interaction with T cells; and a severe B cell-intrinsic block in plasma cell differentiation. Thus, our study presents a new perspective on Cdc42 as key regulator of B cell physiology.

Figures
Products